A Multicenter, Randomized, Double-blind, Placebo-controlled Phase 2b Trial to Evaluate the Efficacy and Safety of YH14618 in Patients With Lumbar Degenerative Disc Disease
Phase of Trial: Phase II
Latest Information Update: 14 Nov 2016
At a glance
- Drugs YH 14618 (Primary)
- Indications Intervertebral disc degeneration
- Focus Therapeutic Use
- Sponsors Yuhan
- 08 Nov 2016 Status changed from recruiting to completed.
- 18 Feb 2016 Status changed from recruiting to active, no longer recruiting, according to ClinicalTrials.gov record.
- 04 Jan 2016 Planned End Date changed from 1 Dec 2016 to 1 Jul 2016, according to ClinicalTrials.gov record.